Assemblybio
2 known investors
Find your way into Assemblybio
Assembly Bio is a biopharmaceutical company developing novel therapeutic candidates for viral and liver diseases, including programs targeting herpesviruses, hepatitis delta virus, hepatitis B virus, and cholestatic liver diseases.
Founders & leadership
JO
Jason OkazakiinChief Executive Officer & President
WD
William Delaney, PhDChief Scientific Officer
AG
Anuj Gaggar, MD, PhDChief Medical Officer
Investors · 2
Frequently asked questions
- What does Assemblybio do?
- Assembly Bio is a biopharmaceutical company developing novel therapeutic candidates for viral and liver diseases, including programs targeting herpesviruses, hepatitis delta virus, hepatitis B virus, and cholestatic liver diseases.
- Who are Assemblybio's investors?
- Assemblybio's investors include Avoro Capital Advisors, Longitude Capital.